Is Prostate Cancer Related to Low Vitamin D Level?
Journal Title: Üroonkoloji Bülteni - Year 2019, Vol 18, Issue 3
Abstract
Objective: Prostate cancer (PC) is the most common malignancy among men worldwide. There are several epidemiological studies linking the risk and outcome of vitamin D with PC. In this study, we aimed to compare vitamin D levels in patients with PC and benign prostatic hyperplasia (BPH). Materials and Methods: Patients with PC and BPH admitted to our urology outpatient clinic between 2017 and 2019 were included in this case-control study. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels were measured to assess vitamin D status. Results: The study was conducted with a total of 256 patients aged between 47 and 86 years between 2018-2019. The mean age of 128 patients with PC was 67.70±7.74 years, and the mean age of 128 patients with BPH was 67.03±7.89 years. There was a statistically significant difference between patients with PC and BPH in terms of 25-hydroxyvitamin D levels. When the patients diagnosed with PC were examined according to their subgroups, the mean 25-hydroxyvitamin D levels of 64 patients with ISUP Grade I tumors were significantly higher than the remaining 64 patients with ISUP Grade II, III and IV tumors. Conclusion: According to our results, vitamin D levels were found to be significantly lower in patients with PC than in patients with BPH, and a significant decrease was found in vitamin D levels as the Gleason score increased. Since PC has a high prevalence and heterogeneous geographical distribution, randomized controlled trials are needed in order to demonstrate the relationship between vitamin D and cancer.
Authors and Affiliations
Aytaç Şahin, Tuncay Toprak, Musab Ali Kutluhan, Ahmet Ürkmez, Çağlar Yıldırım, Ayhan Verit
Keywords
Related Articles
- EP ID EP634296
- DOI 10.4274/uob.galenos.2019.1221
- Views 95
- Downloads 0
Contemporary Trends in Adjuvant and Neoadjuvant Treatment for Renal Cell Carcinoma
Renal cell carcinoma is an increasingly significant cancer in which surgical resection is still the sole curative approach. There is a risk of recurrence in one-third of patients after surgery. Successful experiences wit...
Prostate-specific Membrane Antigen-Based Nanomedicine Applications in the Diagnosis and Treatment of Prostate Cancer
Nanomedicine is a branch of nanotechnology that includes the development of nanostructures and nanoanalytical systems for various medical applications. The rapid development of nanomedicine offers new possibilities in ca...
Bladder Leiomyoma in Men: Report of Two Cases and Review of the Literatüre
Leiomyomas, which originate from smooth muscle cells, are considered as a benign mesenchymal neoplasm and rarely seen in the bladder. The clinical presentation of bladder leiomyoma might vary according to the size and lo...
Squamous Metaplasia and Its Management in Non-malignant Bladder Diseases
Objective: To reveal possible associations between non-malignant bladder disease and malignancy by evaluating the pathologic examination results of patients who underwent cystectomy for non-malignant diseases and to sugg...
What is the Color of Cancer?
Objective: To investigate the colors that evokes cancer in the patients with prostate, lung and breast cancer, and in healthy controls. Materials and Methods: A visual card in one of the 9 colors (white, red, orange, ye...